{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:45:03Z","timestamp":1788749103586,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Union FP7 RID-RTI","award":["304865"],"award-info":[{"award-number":["304865"]}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijid.2018.02.021","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:09:31Z","timestamp":1519963771000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Martin","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-5735","authenticated-orcid":false,"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-8077","authenticated-orcid":false,"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2018.02.021_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2008.0191","article-title":"Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid","volume":"25","author":"Archin","year":"2009","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.ijid.2018.02.021_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2018.02.021_bib0015","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1074\/jbc.M114.605428","article-title":"Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1","volume":"290","author":"Campbell","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2018.02.021_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005007","article-title":"Phenylbutyrate is bacteriostatic against Mycobacterium tuberculosis and regulates the macrophage response to infection, synergistically with 25-hydroxy-vitamin D(3)","volume":"11","author":"Coussens","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2018.02.021_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2016.01.009","article-title":"Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid","volume":"214","author":"Crespillo","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.ijid.2018.02.021_bib0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.imbio.2011.11.010","article-title":"Impact of valproic acid on dendritic cells function","volume":"217","author":"Frikeche","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijid.2018.02.021_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Fu","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijid.2018.02.021_bib0040","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/EC.00189-14","article-title":"Protein acetylation and acetyl coenzyme a metabolism in budding yeast","volume":"13","author":"Galdieri","year":"2014","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijid.2018.02.021_bib0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18632\/genesandcancer.65","article-title":"Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy","volume":"6","author":"Haery","year":"2015","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijid.2018.02.021_bib0050","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3892\/or.2013.2747","article-title":"Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis","volume":"30","author":"Han","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijid.2018.02.021_bib0055","doi-asserted-by":"crossref","DOI":"10.3892\/or.2013.2747","article-title":"Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis","author":"Han","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijid.2018.02.021_bib0060","series-title":"Access programs for vorinostat","author":"Hematology ASo","year":"2015"},{"key":"10.1016\/j.ijid.2018.02.021_bib0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.ijid.2018.02.021_bib0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2013a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2018.02.021_bib0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2146\/ajhp090247","article-title":"Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma","volume":"67","author":"Kavanaugh","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijid.2018.02.021_bib0080","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/civ621","article-title":"Immune cell regulatory pathways unexplored as host-directed therapeutic targets for Mycobacterium tuberculosis: an opportunity to apply precision medicine innovations to infectious diseases","volume":"61","author":"Mahon","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.02.021_bib0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12890-016-0213-5","article-title":"Lung functions among patients with pulmonary tuberculosis in Dar es Salaam\u2014a cross-sectional study","volume":"16","author":"Manji","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijid.2018.02.021_bib0090","series-title":"Drug interaction checker","author":"Medscape","year":"2017"},{"key":"10.1016\/j.ijid.2018.02.021_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138340","article-title":"Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial","volume":"10","author":"Mily","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2018.02.021_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.07.008","article-title":"Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection","volume":"122","author":"Nelson","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2018.02.021_bib0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijid.2018.02.021_bib0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijid.2018.02.021_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020987","article-title":"Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells","volume":"6","author":"Petruccelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2018.02.021_bib0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1473-3099(15)70008-3","volume":"15","author":"Ravimohan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2018.02.021_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15252\/emmm.201404137","article-title":"Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion","volume":"7","author":"Schiebler","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ijid.2018.02.021_bib0130","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/civ609","article-title":"Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines","volume":"61Suppl 3","author":"Schito","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.02.021_bib0135","article-title":"Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms","volume":"8","author":"Silva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2018.02.021_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2018.02.021_bib0145","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/jac\/dku166","article-title":"Simvastatin increases the in vivo activity of the first-line tuberculosis regimen","volume":"69","author":"Skerry","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2018.02.021_bib0150","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1016\/j.febslet.2007.07.030","article-title":"Valproate induces apoptosis by inducing accumulation of neutral lipids which was prevented by disruption of the SIR2 gene in Saccharomyces cerevisiae","volume":"581","author":"Sun","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijid.2018.02.021_bib0155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2018.02.021_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2018.02.021_bib0165","series-title":"Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs","author":"WHO","year":"2008"},{"key":"10.1016\/j.ijid.2018.02.021_bib0170","series-title":"Global tuberculosis report 2015","author":"WHO","year":"2015"},{"key":"10.1016\/j.ijid.2018.02.021_bib0175","series-title":"Model list of essential medicines","author":"WHO","year":"2015"},{"key":"10.1016\/j.ijid.2018.02.021_bib0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri3813","article-title":"Advancing host-directed therapy for tuberculosis","volume":"15","author":"Wallis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2018.02.021_bib0185","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1021\/bi200156t","article-title":"Reversible acetylation and inactivation of Mycobacterium tuberculosis acetyl-CoA synthetase is dependent on cAMP","volume":"50","author":"Xu","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijid.2018.02.021_bib0190","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1007\/s11033-014-3662-z","article-title":"Dilazep synergistically reactivates latent HIV-1 in latently infected cells","volume":"41","author":"Zeng","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ijid.2018.02.021_bib0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/joim.12256","article-title":"Inflammation and tuberculosis: host-directed therapies","volume":"277","author":"Zumla","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijid.2018.02.021_bib0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrd4696","article-title":"Towards host-directed therapies for tuberculosis","volume":"14","author":"Zumla","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijid.2018.02.021_bib0205","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/cid\/civ631","article-title":"Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the Pasteur-Bechamp debates","volume":"61","author":"Zumla","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.02.021_bib0210","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218300572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218300572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:22:01Z","timestamp":1603923721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971218300572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"alternative-id":["S1201971218300572"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.02.021","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}